Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note released on Monday. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Trading Down 31.0 %

Shares of CALA stock opened at $0.02 on Monday. Calithera Biosciences has a 1-year low of $0.01 and a 1-year high of $0.50. The stock’s fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.03.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.